Opportunities Preloader

Please Wait.....

Report

Consumer Health in the US

Market Direction I 2024-09-17 I 129 Pages I Euromonitor

In 2024, the consumer health landscape in the US is marked by a moderated environment across various categories. Inflationary pressures have eased, leading to slightly slower price increases, while seasonal categories such as cough, cold, and allergy remedies (CCAs) continue to stabilise after the peaks observed in 2022. Private label offerings have also moderated, as the cost of branded products has normalised and supply chain efficiencies improved.

Euromonitor International's Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Consumer Health in the US
Euromonitor International
September 2024

List Of Contents And Tables

CONSUMER HEALTH IN THE US
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Analgesics overall to see a softer value performance in 2024
A new class of pain relief prescription medicine could bring change to analgesics
Continued momentum in topical analgesics/anaesthetic fuelled by new product launches
PROSPECTS AND OPPORTUNITIES
Aspirin and naproxen to witness continued declines over the forecast period
Emphasis on menstrual health could lead to combination menstrual pain management products
Paediatric-oriented players could disrupt analgesics through format and ingredient formulations
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Cough, cold and allergy (hay fever) remedies continues its return to normality
Private label momentum slows amidst easing price pressures
Haleon's Robitussin recalled for microbial contamination
PROSPECTS AND OPPORTUNITIES
Climate change to influence stable consumer uptake for cough, cold, and allergy remedies
FDA's phenylephrine ruling could disrupt major players in cough and cold remedies
Pharyngeal preparations to experience cannibalisation from medicated confectionery
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Digestive remedies continues to benefit from post-pandemic health changes and wellness-oriented product developments
Digestive remedies direct-to-consumer disruptor brand Wonderbelly enters CVS
Big brands and direct-to-consumer brands compete with product launches
PROSPECTS AND OPPORTUNITIES
Laxatives well-positioned for US demographic shifts
PPIs set to see significantly reduced consumer intake over the forecast period due to side-effects and substitutes
Digestive support products positioned for women's health could witness heightened mergers and acquisitions activity
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Mixed performance expected in dermatologicals in 2024, as consumers continue struggling with inflation, economic uncertainty, and ongoing price increases
New policy changes and rise in service-based offerings expected to impact the performance of antiparasitics/lice (head and body) treatments
Top consumer priorities of safety and skin health spur innovation in dermatologicals
PROSPECTS AND OPPORTUNITIES
Consumer interest in natural and non-medicated solutions could moderate the growth of dermatologicals over the forecast period
Digital engagement could provide a promising avenue to improve brand perception, build communities, and educate consumers
The competitive environment is set to intensify, with rising pressure expected from beauty and personal care, as well as prescription-based offerings
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Patch format continues to witness a stagnant performance
Haleon's international divestments hint at uncertain trajectory for the domestic landscape
More direct-to-consumer brands on the horizon
PROSPECTS AND OPPORTUNITIES
Nicotine cessation medication: Potential category disruptor?
Uncertain regulatory landscape for ZYN nicotine pouches could benefit traditional NRT solutions
Vaping and usage of nicotine pouches increasing amongst younger generations in the US
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Value growth in sleep aids continues to fall as traditional products lose their edge
Natural sleep support ingredients see benefits from digital trends, such as the "sleepy girl mocktail"
DTC and legacy brands look to innovate through sleep supplementation in new product launches
PROSPECTS AND OPPORTUNITIES
How legacy players will look to innovate in a category under threat
Retail e-commerce expected to continue to play a major role in the future of sleep aids and sleep adjacent categories
Paediatric sleep products could move away from melatonin positioning due to concerns
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
The heightened allergy season is driving demand for allergy eye care products and sparking innovation
Dry eye conditions remain at the forefront of advances in eye care offerings
Recalls of eye drops highlight the significance of eye health education
PROSPECTS AND OPPORTUNITIES
Worsening climate conditions present an opportunity for eye care players
Sustainable formulations will be a crucial factor in terms of premiumisation
Beauty positioning shows promise for standard eye care
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Maturity continues to limit growth in wound care
Kenvue remains at the forefront of wound care, offering a diverse range of high-quality products
Retail e-commerce emerges as a popular distribution channel for wound care
PROSPECTS AND OPPORTUNITIES
Product innovation, while currently constrained, will be key to drive value growth
Dangerous "forever chemicals" may hinder the growth prospects for wound care
Maturity and declining population to limit volume growth; however, sustainability credentials set to become an important selling point
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Vitamins maintains a steady value growth performance
Unique marketing tactics to stimulate growth
Private label benefits from affordability and value
PROSPECTS AND OPPORTUNITIES
Vitamins set to face increasing rivalry from functional food and drinks
Rise in personalised approach to focus on targeted health concerns
Innovation is key to ensuring continuous growth in value sales
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dietary supplements experiences steady value growth; protein-rich dietary supplements benefit from heightened health awareness
The rise of mergers and acquisitions in the wellness industry
New supplement guidelines adopted by Amazon
PROSPECTS AND OPPORTUNITIES
Dietary supplements set to maintain solid growth; launches will be targeted towards specific consumer groups
Products for women's health and beauty from within on the rise
Multifunctionality and personalisation set to gain further momentum
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Weight management and wellbeing sees a steeper value decline
Legislative restrictions on sale of diet pills and muscle-building supplements to teens
Changing perception of methods of weight loss
PROSPECTS AND OPPORTUNITIES
Consumers' potential re-entry to the category after taking GLP-1 drugs
Lifestyle shifts in terms of diet and exercise remain top-of-mind for weight management consumers
GLP-1 support products on the rise in weight management and wellbeing
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Another strong year for sports nutrition, owing to an increased focus on health and fitness
Innovation plays a crucial role in reaching a broader audience
Retail e-commerce and omnichannel strategy strengthen penetration of sports nutrition
PROSPECTS AND OPPORTUNITIES
Personalisation set to gain momentum in sports nutrition
Cross-industry competition increases in response to the blurring wellness concept
Sustainable sports nutrition set to gain further momentum
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Herbal/traditional products experiences another year of growth
Innovation is key to maintaining growth for herbal/traditional products
Rise of adaptogens and mushrooms as brain and cognitive health products
PROSPECTS AND OPPORTUNITIES
Mixed performance of herbal/traditional dietary supplements as a method for weight loss
Continued interest in women's health could highlight menstrual health support and drive integrated solutions for managing menstrual pain
Concerns about efficacy and safety could lead to further regulation, hinting at the potential slower growth of herbal/traditional products
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN THE US
KEY DATA FINDINGS
2024 DEVELOPMENTS
Paediatric analgesics and cough, cold and allergy remedies set to continue to decline from their 2022 peak
Paediatric sleep offerings to expand ingredient innovation beyond melatonin products
Increased emphasis on monitoring nutritional trends and balanced supplement intake
PROSPECTS AND OPPORTUNITIES
Opportunities for players in paediatric analgesics to disrupt the market through format and ingredient innovation
Focus on natural/herbal trends, and new launches to widen the customer base
Positive outlook for paediatric vitamins and dietary supplements
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • €2675.00
  • €5350.00
  • €8025.00
  • ADD TO BASKET
  • BUY NOW